Holmen Sheri L, Williams Bart O
Molecular Medicine and Virology Group, Van Andel Research Institute, Grand Rapids, Michigan 49503, USA.
Cancer Res. 2005 Sep 15;65(18):8250-5. doi: 10.1158/0008-5472.CAN-05-1173.
Malignant gliomas can be induced in mice through the combined expression of activated forms of both KRas and Akt in glial progenitor cells. To determine the reliance of these tumors on continued KRas signaling in vivo, we generated a viral vector that allows the expression of KRas to be controlled post-delivery. Tumor-free survival rates were compared between those animals with continued KRas expression and animals in which KRas expression was suppressed. KRas signaling was found to be required for the maintenance of these tumors in vivo; inhibition of KRas expression resulted in apoptotic tumor regression and increased survival. Subsequent reexpression of KRas reinitiated tumor growth, indicating that a percentage of the progenitor cells survived and retained tumorigenic properties.
通过在神经胶质祖细胞中联合表达活化形式的KRas和Akt,可在小鼠中诱导出恶性胶质瘤。为了确定这些肿瘤在体内对持续KRas信号传导的依赖性,我们构建了一种病毒载体,该载体能够在递送后控制KRas的表达。比较了持续表达KRas的动物与KRas表达被抑制的动物的无瘤生存率。发现KRas信号传导是这些肿瘤在体内维持所必需的;抑制KRas表达导致肿瘤细胞凋亡性消退并提高生存率。随后KRas的重新表达重新启动了肿瘤生长,这表明一定比例的祖细胞存活并保留了致瘤特性。